{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:05:30Z","timestamp":1792821930326,"version":"4.5.0"},"reference-count":36,"publisher":"BMJ","issue":"1","funder":[{"name":"Sun Pharmaceutical Industries Ltd., India,","award":["Funded through independent medical grant"],"award-info":[{"award-number":["Funded through independent medical grant"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2019,6,22]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine glycemic control in adult patients with type 2 diabetes receiving antidiabetic therapy as part of routine healthcare in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This was a retrospective analysis of cross-sectional data of patients with type 2 diabetes receiving oral hypoglycemic agents (OHAs) with or without insulin between 2015 and 2017. We assessed proportion of patients with uncontrolled glycemia and performed logistic regression to evaluate its association with various risk factors and microvascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 55\u2009639 eligible records were identified; mean age of patients was 54.31 (\u00b111.11) years. One-third of the study population had microvascular complications, predominantly neuropathy. Nearly 76.6% of patients had uncontrolled glycated hemoglobin (HbA1c) \u22657% (53 mmol\/mol); 62% of these patients had HbA1c between 7% and 8% (53\u201364\u2009mmol\/mol). Glycemic control from combination of OHAs with or without insulin varied between 14.2% and 24.8%. In multivariate analysis, factors statistically associated with uncontrolled glycemia were obesity (OR: 1.15), hypertension (stage I OR: 1.65 and stage II OR: 2.73) and diabetes duration &gt;5 years (OR: 1.19) (p&lt;0.001). Similarly, the odds of having any microvascular complication increased with duration of diabetes (past 1\u20132 years, OR: 1.67; 2\u20135 years, OR: 2.53; &gt;5 years, OR: 4.01; p&lt;0.0001), hypertension (stage I, OR: 1.18 and stage II, OR: 1.34; p&lt;0.05) and uncontrolled HbA1c (OR: 1.28; p&lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Indian population with type 2 diabetes has a high burden (76.6%) of poor glycemic control. This study highlights the need for early implementation of optimum diabetes pharmacotherapy to maintain recommended glycemic control, thereby reducing burden of microvascular complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2019-000654","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T07:25:16Z","timestamp":1563175516000},"page":"e000654","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-9549","authenticated-orcid":false,"given":"Surendra S","family":"Borgharkar","sequence":"first","affiliation":[{"name":"Sun Pharmaceutical Industries Ltd, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma S","family":"Das","sequence":"additional","affiliation":[{"name":"Sciformix, A Covance Company, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,7,14]]},"reference":[{"key":"2025073113200449000_7.1.e000654.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023"},{"key":"2025073113200449000_7.1.e000654.2","unstructured":"International Diabetes Federation, 8 edition . IDF diabetes atlas, fact sheet South East Asia, 2017. Available: http:\/\/diabetesatlas.org\/resources\/2017-atlas.html [Accessed 1 Aug 2018]."},{"key":"2025073113200449000_7.1.e000654.3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073113200449000_7.1.e000654.4","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-018-1002-8","article-title":"Diabetes in South Asians: phenotype, clinical presentation, and natural history","volume":"18","author":"Unnikrishnan","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2025073113200449000_7.1.e000654.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.53"},{"key":"2025073113200449000_7.1.e000654.6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.7.815"},{"key":"2025073113200449000_7.1.e000654.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025073113200449000_7.1.e000654.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S002"},{"key":"2025073113200449000_7.1.e000654.9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabres.2017.09.002","article-title":"New IDF clinical practice recommendations for managing type 2 diabetes in primary care","volume":"132","author":"Aschner","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073113200449000_7.1.e000654.10","doi-asserted-by":"publisher","DOI":"10.4158\/CS-2017-0153"},{"key":"2025073113200449000_7.1.e000654.11","unstructured":"ICMR diabetes guidelines, 2018. Available: https:\/\/medibulletin.com\/wp-content\/uploads\/2018\/05\/ICMR.diabetesGuidelines.2018.pdf [Accessed 3 Aug 2018]."},{"key":"2025073113200449000_7.1.e000654.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13410-018-0604-7","article-title":"RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017","volume":"38","author":"Bajaj","year":"2018","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2025073113200449000_7.1.e000654.13","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.2337\/dcS15-3007","article-title":"Clinical considerations for use of initial combination therapy in type 2 diabetes","volume":"39 Suppl 2","author":"Cahn","year":"2016","journal-title":"Diabetes Care"},{"key":"2025073113200449000_7.1.e000654.14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15277\/bjdvd.2015.019","article-title":"Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review","volume":"15","author":"Khunti","year":"2015","journal-title":"Br J Diabetes"},{"key":"2025073113200449000_7.1.e000654.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1974"},{"key":"2025073113200449000_7.1.e000654.16","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816645121"},{"key":"2025073113200449000_7.1.e000654.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"2025073113200449000_7.1.e000654.18","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"2025073113200449000_7.1.e000654.19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ihj.2017.10.007","article-title":"A study on the glycemic, lipid and blood pressure control among the type 2 diabetes patients of North Kerala, India","volume":"70","author":"Kumar","year":"2018","journal-title":"Indian Heart J"},{"key":"2025073113200449000_7.1.e000654.20","unstructured":"Raj P , Malpani BK , Anand Moses CR , et al . The National diabetes registry in India. British Journal of Medical and Health Research 2016;3."},{"key":"2025073113200449000_7.1.e000654.21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0018"},{"key":"2025073113200449000_7.1.e000654.22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4239\/wjd.v9.i1.40","article-title":"Association of obesity with hypertension and type 2 diabetes mellitus in India: a meta-analysis of observational studies","volume":"9","author":"Babu","year":"2018","journal-title":"World J Diabetes"},{"key":"2025073113200449000_7.1.e000654.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019697","article-title":"Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China","volume":"8","author":"Li","year":"2018","journal-title":"BMJ Open"},{"key":"2025073113200449000_7.1.e000654.24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13410-013-0118-2","article-title":"Evaluation of diabetes self-care with self-monitoring of blood glucose among type 2 diabetic patients and its impact on HbA1c","volume":"33","author":"Shaji","year":"2013","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2025073113200449000_7.1.e000654.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000512","article-title":"Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study","volume":"6","author":"Gordon","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Suppl 2","key":"2025073113200449000_7.1.e000654.26","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.4103\/2230-8210.104135","article-title":"Baseline characteristics of the improve control study population: a study to evaluate the effectiveness of a standardized healthcare professionals training program","volume":"16","author":"Sharma","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"2025073113200449000_7.1.e000654.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2013-000005","article-title":"Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study III (SN-DREAMS III), report no 2","volume":"2","author":"Raman","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025073113200449000_7.1.e000654.28","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.129715"},{"key":"2025073113200449000_7.1.e000654.29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jdi.12223","article-title":"Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting","volume":"5","author":"Bansal","year":"2014","journal-title":"J Diabetes Investig"},{"key":"2025073113200449000_7.1.e000654.30","unstructured":"Agrawal RPR , Ola V , Bishnoi P , et al . Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. J Assoc Physicians India 2014;62."},{"key":"2025073113200449000_7.1.e000654.31","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0069"},{"key":"2025073113200449000_7.1.e000654.32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073113200449000_7.1.e000654.33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.aogh.2016.01.002","article-title":"Diabetes care in India","volume":"81","author":"Joshi","year":"2015","journal-title":"Ann Glob Health"},{"key":"2025073113200449000_7.1.e000654.34","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12233"},{"key":"2025073113200449000_7.1.e000654.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000519","article-title":"Goal study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice","volume":"6","author":"Al Mansari","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025073113200449000_7.1.e000654.36","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2019-000654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:20:22Z","timestamp":1753993222000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2019-000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,7,14]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bmjdrc-2019-000654"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2019-000654","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}